|
|
Gene Symbol |
SERPINC1 |
|
Aliases |
AT3, AT3D, ATIII, ATIII-R2, ATIII-T1, ATIII-T2, THPH7 |
|
Entrez Gene ID |
|
|
Gene Name |
Serpin family C member 1 |
|
Chromosomal Location |
1q25.1 |
|
HGNC ID |
|
|
Summary |
The protein encoded by this gene, antithrombin III, is a plasma protease inhibitor and a member of the serpin superfamily. This protein inhibits thrombin as well as other activated serine proteases of the coagulation system, and it regulates the blood coagulation cascade. The protein includes two functional domains: the heparin binding-domain at the N-terminus of the mature protein, and the reactive site domain at the C-terminus. The inhibitory activity is enhanced by the presence of heparin. Numerous mutations have been identified for this gene, many of which are known to cause antithrombin-III deficiency which constitutes a strong risk factor for thrombosis. [provided by RefSeq, Dec 2019]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Antithrombin-III, antithrombin III isoform, serine (or cysteine) proteinase inhibitor, clade C (antithrombin), member 1, serpin peptidase inhibitor clade C member 1, serpin peptidase inhibitor, clade C (antithrombin), member 1 |
|
Function |
Most important serine protease inhibitor in plasma that regulates the blood coagulation cascade. AT-III inhibits thrombin, matriptase-3/TMPRSS7, as well as factors IXa, Xa and XIa. Its inhibitory activity is greatly enhanced in the presence of heparin. |
|
|
|
|
|
UniProt |
|
|
PDB |
1ANT, 1ATH, 1AZX, 1BR8, 1DZG, 1DZH, 1E03, 1E04, 1E05, 1JVQ, 1LK6, 1NQ9, 1OYH, 1R1L, 1SR5, 1T1F, 1TB6, 2ANT, 2B4X, 2B5T, 2BEH, 2GD4, 2HIJ, 2ZNH, 3EVJ, 3KCG, 4EB1 |
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
|
P01215 |
P01215 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Blood Disorders |
Disseminated Intravascular Coagulation |
|
Blood Coagulation Disorders |
|
Cardiovascular Diseases |
Acute Coronary Syndrome |
|
Deep Vein Thrombosis |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Antithrombin Deficiency |
3162733, 3179438, 3805013, 3828226, 8664906, 24082793, 3580302, 7989582, 28317092, 7082587, 28492532, 8476848, 6871107, 1873224, 3238650, 1555650, 24956267, 3080419, 6871478, 2794060, 2349545, 3055413, 9845533, 1469094, 6204398, 6636045, 4082101, 11713457, 3169232, 27322195, 3605071, 2, 6435583 |
Digestive System Diseases |
Liver Failure |
|
Endocrine System Diseases |
PCOS |
|
Nervous System Diseases |
Cerebral Thrombosis |
|
Cerebral Thrombus |
|
Renal Disorder |
Nephrotic Syndrome |
|
Reproductive disorders |
Preeclampsia |
|
Respiratory Tract Diseases |
Respiratory Distress Syndrome |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
TAFI, PAI-1,fibrinogen,thrombomodulin |
|
|
|
Related
|
|
This study showed that plasma levels of TAFI, PAI-1, D-dimer, AT III and thrombomodulin were significantly increased in women with PCOS compared with age- and BMI-matched controls. |
|
|
|